Form 4: FibroGen CFO Juan Graham Reports Tax-Related Stock Disposals
SEC Form 4 Filing
Juan Graham, CFO of FibroGen, Inc., reports the disposal of shares to cover tax obligations arising from the vesting of restricted stock units.
Summary
- On June 6, 2024, Juan Graham, the Chief Financial Officer of FibroGen, Inc., disposed of 17,797 shares of common stock at a price of $1.19 per share to cover tax obligations.
- Following this transaction, Graham directly owns 185,672 shares of FibroGen common stock.
- On June 7, 2024, Graham disposed of 1,182 shares of common stock at a price of $1.10 per share for the same reason.
- After the second transaction, Graham directly owns 184,490 shares of FibroGen common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock disposals for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The disposal of shares by the CFO may have a minor impact on shareholders due to the increased supply of shares in the market, but it is primarily related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Disposal of 17,797 shares of common stock at $1.19 per share. |
| 06/07/2024 | Disposal of 1,182 shares of common stock at $1.10 per share. |
| 06/10/2024 | Date of signature by Michael Hom, Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.